Publication | Open Access
Herpes simplex virus–1 encephalitis can trigger anti-NMDA receptor encephalitis: Case report
188
Citations
9
References
2013
Year
ImmunologyViral PathogenesisPathologyViral PersistenceNeurologyNeuroimmunologyNmdar AntibodiesHerpes Simplex Virus VaccinesAnti-nmdar Encephalitis.4NeurovirologyVirologyImmunologic DiseaseChronic Viral InfectionEncephalitisAnti-nmda Receptor EncephalitisCase ReportMolecular VirologyPathogenesisAntiviral ResponseNmda ReceptorHerpesvirusesVirus-host InteractionMultiple SclerosisMedicine
Relapsing symptoms post herpes simplex virus-1 (HSV) encephalitis (HSVE) usually occur a few weeks after viral therapy and represent either 1) a true viral relapse of HSVE (CSF PCR positive for HSV, new necrotic lesions on brain MRI, and response to acyclovir therapy) or 2) a disorder postulated to be immune-mediated (CSF negative for HSV, no new necrotic lesions, and no response to acyclovir).1,2 It has been suggested that this immune-mediated disorder may be related to NMDA receptor (NMDAR) antibodies,3 and we recently reported a child in whom relapsing symptoms post HSVE were the presentation of anti-NMDAR encephalitis.4 We report an adult with this disorder, demonstrate that synthesis of NMDAR antibodies began after HSVE, and show that relapsing symptoms were due to steroid-responsive anti-NMDAR encephalitis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1